Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerBilling CodesHelminthiasesICD-10-CM b69-cysticercosis
    Ask Trek AI about this page

    ICD-10-CM Code For Cysticercosis: Group Overview

    The International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) code group B69 includes diagnoses for cysticercosis, covering infections by the larval Taenia solium that may involve the brain (neurocysticercosis), eyes, muscles, or subcutaneous tissues. These ICD-10-CM diagnosis codes are used to document parasitic infection presentations, capturing disease severity, organ involvement, or clinical complexity relevant to this group. Accurate coding within the ICD-10-CM B69 group supports proper claim adjudication / complete clinical documentation / appropriate reimbursement.

    Customize your policy alerts

    Sign up for ICD-10-CM Code For Cysticercosis: Group Overview policy alerts

    Get alerted when relevant policies change without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    ICD-10-CM B69: Cysticercosis Overview

    The ICD-10-CM B69 group represents cysticercosis, an infection caused by the larval stage of the pork tapeworm Taenia solium that can affect the central nervous system, eyes, muscles, and subcutaneous tissues. These diagnoses target parasitic helminth infections with potential focal organ involvement and varying clinical severity. Accurate coding matters for appropriate claim processing and ensures clinical records reflect organ-specific manifestations that influence care and reimbursement.

    Table of contents

    Progress1 / 5

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    When to Use

    Use a code from this group when clinical documentation confirms cysticercosis or anatomic site-specific manifestations attributable to Taenia solium larvae. Select the code that corresponds to the infected organ system and documented complications or sequelae to accurately represent clinical complexity.

    ICD-10-CM Codes

    5 rows

    ICD-10-CM CodeDescription
    B69.0Cysticercosis of central nervous system
    B69.1Cysticercosis of eye
    B69.81Myositis in cysticercosis
    B69.89Cysticercosis of other sites
    B69.9Cysticercosis, unspecified

    DRG Codes

    3 rows

    DRG CodeDescription
    371Major Gastrointestinal Disorders and Peritoneal Infections with MCC
    372Major Gastrointestinal Disorders and Peritoneal Infections with CC
    373Major Gastrointestinal Disorders and Peritoneal Infections without CC/MCC

    Related Codes

    B65-SCHISTOSOMIASIS-BILHARZIASIS

    ICD-10-CM Code For Schistosomiasis Bilharziasis: Group Overview

    B66-OTHER-FLUKE-INFECTIONS

    ICD-10-CM Code For Other Fluke Infections: Group Overview

    B67-ECHINOCOCCOSIS

    ICD-10-CM Code For Echinococcosis: Group Overview

    B68-TAENIASIS

    ICD-10-CM Code For Taeniasis: Group Overview

    B70-DIPHYLLOBOTHRIASIS-AND-SPARGANOSIS

    ICD-10-CM Code For Diphyllobothriasis And Sparganosis: Group Overview

    B71-OTHER-CESTODE-INFECTIONS

    ICD-10-CM Code For Other Cestode Infections: Group Overview

    B72-DRACUNCULIASIS

    ICD-10-CM Code For Dracunculiasis: Group Overview

    B73-ONCHOCERCIASIS

    ICD-10-CM Code For Onchocerciasis: Group Overview

    B74-FILARIASIS-AND-FILARIAL-INFECTIONS

    ICD-10-CM Code For Filariasis: Group Overview

    B75-TRICHINELLOSIS

    ICD-10-CM Code For Trichinellosis: Group Overview

    Showing 1–10 of 18

    Frequently Asked Questions

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.